Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Shares IssuedShares OutstandingShares Outstanding
Ratios

Immuneering (IMRX) Shares Issued (2021 - 2026)

Immuneering's Shares Issued history spans 6 years, with the latest figure at $170325.0 for Q1 2026.

  • On a quarterly basis, Shares Issued rose 27.21% to $170325.0 in Q1 2026 year-over-year; TTM through Mar 2026 was $1.3 million, a 67.68% decrease, with the full-year FY2025 number at $368532.0, down 1.63% from a year prior.
  • Shares Issued came in at $170325.0 for Q1 2026, up from -$53378.0 in the prior quarter.
  • The five-year high for Shares Issued was $4.2 million in Q3 2024, with the low at -$732458.0 in Q2 2024.
  • Historically, Shares Issued has averaged $419602.2 across 5 years, with a median of $133892.0 in 2025.
  • Peak annual rise in Shares Issued hit 1068.89% in 2023, while the deepest fall reached 1138.06% in 2023.
  • Year by year, Shares Issued stood at $42098.0 in 2022, then crashed by 1138.06% to -$437003.0 in 2023, then soared by 185.73% to $374652.0 in 2024, then plummeted by 114.25% to -$53378.0 in 2025, then soared by 419.09% to $170325.0 in 2026.
  • Business Quant data shows Shares Issued for IMRX at $170325.0 in Q1 2026, -$53378.0 in Q4 2025, and $1.3 million in Q3 2025.